Related Experiment Video
Updated: Jul 16, 2026

Determining Soil-transmitted Helminth Infection Status and Physical Fitness of School-aged Children
Published on: August 22, 2012
Incidence of clinically significant bacteraemia in children who present to hospital in Kenya: community-based
A J Brent1, I Ahmed, M Ndiritu
1Wellcome Trust/KEMRI Centre for Geographic Medicine Research, Coast, PO Box 230, Kilifi, Kenya. andrew_brent@doctors.org.uk
Insights
Invasive bacterial disease, including pneumococcal bacteraemia, is twice as common in Kenyan children as previously thought. These findings support the urgent need for pneumococcal vaccine implementation in sub-Saharan Africa.
Area of Science:
- Pediatrics
- Infectious Diseases
- Public Health
Background:
- Invasive bacterial disease (IBD) burden estimates in sub-Saharan Africa often underestimate the true incidence by focusing only on hospitalized patients.
- Underestimation of IBD incidence hampers effective vaccine implementation strategies in the region.
- This study aimed to determine the incidence of bacteraemia in all children presenting to a Kenyan hospital, regardless of their clinical condition or admission status.
Purpose of the Study:
- To accurately assess the incidence of bacteraemia in children presenting to a hospital in Kenya.
- To evaluate the clinical significance of bacteraemia and the effectiveness of clinical signs in its diagnosis.
- To provide data supporting public health interventions, such as vaccine introduction.
Main Methods:
- A community-based observational study involving blood cultures from 1093 children attending a Kenyan hospital's outpatient department.
- Utilized a Demographic Surveillance System to estimate bacteraemia incidence.
- Investigated the clinical presentation, outcomes, and diagnostic utility of clinical signs for bacteraemia.
Main Results:
- The overall yearly incidence of bacteraemia was 2440 per 100,000 children under 2 years and 1192 per 100,000 children under 5 years.
- Pneumococcal bacteraemia incidence was 597 per 100,000 children under 5 years.
- Clinically significant bacteraemia was twice as common, and pneumococcal bacteraemia four times as common, as previously estimated, with clinical signs proving poor indicators.
Conclusions:
- Clinically significant bacteraemia is more prevalent in Kenyan children than previously reported.
- The high incidence of pneumococcal bacteraemia strongly supports the introduction and widespread use of the pneumococcal vaccine in sub-Saharan Africa.
- Accurate incidence data are crucial for effective disease control and prevention programs.
Background:
Estimates of the burden of invasive bacterial disease in sub-Saharan Africa have previously relied on selected groups of patients, such as inpatients; they are, therefore, probably underestimated, potentially hampering vaccine implementation. Our aim was to assess the incidence of bacteraemia in all children presenting to a hospital in Kenya, irrespective of clinical presentation or decision to admit.
Methods:
We did a community-based observational study for which we cultured blood from 1093 children who visited a Kenyan hospital outpatient department. We estimated bacteraemia incidence with a Demographic Surveillance System, and investigated the clinical significance of bacteraemia and the capacity of clinical signs to identify cases.
Results:
The yearly incidence of bacteraemia per 100,000 children aged younger than 2 years and younger than 5 years was 2440 (95% CI 1307-3573) and 1192 (692-1693), respectively. Incidence of pneumococcal bacteraemia was 597 (416-778) per 100,000 person-years of observation in children younger than age 5 years. Three-quarters of episodes had a clinical focus or required admission, or both; one in six was fatal. After exclusion of children with occult bacteraemia, the incidence of clinically significant bacteraemia per 100,000 children younger than age 2 years or 5 years fell to 1741 (790-2692) and 909 (475-1343), respectively, and the yearly incidence of clinically significant pneumococcal bacteraemia was 436 (132-739) per 100,000 children younger than 5 years old. Clinical signs identified bacteraemia poorly.
Interpretation:
Clinically significant bacteraemia in children in Kilifi is twice as common, and pneumococcal bacteraemia four times as common, as previously estimated. Our data support the introduction of pneumococcal vaccine in sub-Saharan Africa.
Related Concept Videos
Factors Affecting the Risk of Infection
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin create...
Development of Human Microbiota
Development of the Oral Microbiota
Amebiasis
Clinical Significance of Antibiotic Resistance

